← Back to all trials
Completed
NCT07950319
Exploring the Use of Fecal Microbiota Transplantation in Treating Diabetes-Related Constipation
Conditions: Functional Constipation (FC), Fecal Microbiota Transplantation, Type 2 Diabetes Mellitus (T2DM)
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 30
Sponsor: Shanghai 10th People's Hospital
Location: Shanghai Tenth People's Hospital Shanghai Shanghai Municipality
Summary
This study aims to retrospectively evaluate the clinical effectiveness and safety of fecal microbiota transplantation (FMT) in treating patients with functional constipation (FC) who also have type 2 diabetes mellitus (T2DM). It analyzes changes in bowel function, glucose metabolism indicators, and gut microbiota structure before and after FMT, and further explores the relationship between donor-related microbiota remodeling, predicted microbial metabolic functions, and clinical outcomes.
Eligibility Criteria
Inclusion Criteria:
1. Clearly diagnosed with functional constipation.
2. Clearly diagnosed with type 2 diabetes.
3. Received FMT treatment between January 2020 and December 2024.
4. Have clinical data before and after FMT treatment.
5. Have stool samples before and after FMT treatment for gut microbiota analysis.
Exclusion Criteria:
1. Combined gastrointestinal malignancies.
2. History of gastrointestinal surgery.
3. Presence of megacolon.
4. History of broad-spectrum antibiotic use.
Source: ClinicalTrials.gov (NCT07950319). StuddyBuddy aggregates publicly available trial information.